
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MCAT CRISPR/Cas9 KO Plasmid (h) | sc-404338 | 20 µg | $397.00 |
MCAT (malonyl-CoA:ACP transacylase) is a mitochondrial enzyme required for mitochondrial fatty acid synthesis (mtFAS) by transferring malonyl groups to acyl carrier protein, enabling elongation of acyl chains used in lipoic acid production. Through its role in generating lipoate, MCAT supports lipoylation of key dehydrogenase complexes such as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, linking mtFAS to central carbon metabolism, redox homeostasis, and mitochondrial energy flux. Perturbation of MCAT activity can influence mitochondrial respiration and metabolite utilization, with downstream effects on oxidative stress and metabolic reprogramming. These processes are relevant to mechanistic studies of mitochondrial dysfunction and metabolism-associated disease biology, including contexts where lipoylation status and TCA-linked enzyme function are altered.
MCAT CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the MCAT gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the MCAT together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the MCAT open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MCAT protein expression.
This CRISPR knockout system enables efficient generation of MCAT-deficient cell models for investigation of MCAT signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.